Filters
Other countries
Results: 1 to 16 of 16
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
NPPA - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 289 | 275 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics, part of Exact Sciences United States | 346 | 160 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Atrial standstill: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 2 | 3 |
|
NPPA Deletion/duplication analysis Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center United States | 2 | 1 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 2 | 1 |
|
Comprehensive Cardiomyopathy NGS Panel Fulgent Genetics United States | 450 | 128 |
|
Cardio-channelopathy-gene-panel MVZ Dr. Eberhard & Partner Dortmund Germany | 35 | 33 |
|
Fulgent Genetics United States | 2 | 1 |
|
Dilated Cardiomyopathy NGS Panel Fulgent Genetics United States | 182 | 78 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Sudden Death Syndrome NGS Panel Fulgent Genetics United States | 168 | 68 |
|
Fulgent Genetics United States | 84 | 24 |
|
Comprehensive Cardiovascular NGS Panel Fulgent Genetics United States | 696 | 250 |
|
Comprehensive Arrhythmia NGS Panel Fulgent Genetics United States | 184 | 76 |
|
Results: 1 to 16 of 16
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.